INO: the balance sheet

MyFinsight

For the year ending 2025-12-31, INO has $74,310,035 in assets. $50,213,759 in debts. $44,273,319 in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	44,273,319
Short-term investments	14,239,145
Prepaid expenses and other current assets, including from affiliated entity	2,610,882
Total current assets	61,123,346
Fixed assets, net	2,527,603
Investments in affiliated entity	2,103,688
Operating lease right-of-use assets	6,542,923
Other assets	2,012,475
Total assets	74,310,035

Accounts payable and accrued expenses-Nonrelated Party	11,053,618
Accounts payable and accrued expenses-Related Party	74,473
Accrued clinical trial expenses	650,680
Common stock warrant liabilities	29,067,162
Operating lease liability	2,822,622
Total current liabilities	43,668,555
Operating lease liability, net of current portion	6,545,204
Total liabilities	50,213,759
Common stockpar value 0.001 authorized shares 600,000,000 at december 31, 2024 and 2023, issued and outstanding 36,099,991 at december31, 2024 and 22,793,075 at december31, 2023	68,997
Additional paid-in capital	1,839,830,405
Accumulated deficit	-1,815,165,163
Accumulated other comprehensive loss	-637,963
Total inovio pharmaceuticals, inc. stockholders equity	24,096,276
Total liabilities and stockholders equity	74,310,035

Unit: Dollar.